Bruker Leads Index Again | GenomeWeb
For the second week in a row, Bruker BioSciences led all gainers in the BCW Index with an increase of 10.8 percent for the five-day trading week ended Tuesday. Last Wednesday, the firm was mentioned in an article on the influential investment website The Motley Fool spotlighting companies with a high percentage of inside stock holders.
 
Bruker’s gains follow last week’s rise of 9.1 percent.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.